Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 10, 1999
A pilot study of the management of uncomplicated candidemia with a standardized protocol of amphotericin BC J Fichtenbaum, M German, W C Dunagan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1997
The effects of cytomegalovirus serology on graft and recipient survival in cadaveric renal transplantation: implications for organ allocationM A Schnitzler, R S Woodward, D C Brennan, et al.
Surgery|May 1, 1997
Impact of cytomegalovirus serology on graft survival in living related kidney transplantation: implications for donor selectionM A Schnitzler, R S Woodward, D C Brennan, et al.
Reviews of Infectious Diseases|May 1, 1991
Antibiotic misuse in two clinical situations: positive blood culture and administration of aminoglycosidesW C Dunagan, R S Woodward, G Medoff, et al.
Pharmacotherapy|March 1, 1997
A randomized, prospective evaluation of an interventional program to discontinue intravenous antibiotics at two tertiary care teaching institutionsT C Bailey, D J Ritchie, S T McMullin, et al.
Proceedings. Symposium on Computer Applications in Medical Care|January 1, 1995
Supporting ad-hoc queries in an integrated clinical databaseS A Steib, R M Reichley, S T McMullin, et al.
The American Journal of Medicine|September 1, 1989
Antimicrobial misuse in patients with positive blood culturesW C Dunagan, R S Woodward, G Medoff, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 16, 1997
Cytomegalovirus and HLA-A, B, and DR locus interactions: impact on renal transplant graft survivalM A Schnitzler, R S Woodward, D C Brennan, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1993
Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxisT C Bailey, W G Powderly, G A Storch, et al.
The American Journal of Medicine|September 1, 1993
Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplantsT C Bailey, N A Ettinger, G A Storch, et al.
Pageof 5